Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
出版年份 2023 全文链接
标题
Rationale and design of the DAPA-MI trial: Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
作者
关键词
-
出版物
AMERICAN HEART JOURNAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-08-28
DOI
10.1016/j.ahj.2023.08.008
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Persistent mortality and heart failure burden of anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention: real-world evidence from the US Medicare Data Set
- (2023) Jack Martin BMJ Open
- Dapagliflozin and New York Heart Association Functional Class in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial
- (2022) John W. Ostrominski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin in acute myocardial infarction: the EMMY trial
- (2022) Dirk von Lewinski et al. EUROPEAN HEART JOURNAL
- Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
- (2022) Pardeep S. Jhund et al. NATURE MEDICINE
- Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
- (2022) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials
- (2021) Peter Rossing et al. Lancet Diabetes & Endocrinology
- Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial
- (2020) Thomas A. Zelniker et al. CIRCULATION
- The win ratio approach for composite endpoints: practical guidance based on previous experience
- (2020) Björn Redfors et al. EUROPEAN HEART JOURNAL
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Systematic Review of Medical Costs Associated with Heart Failure in the USA (2014–2020)
- (2020) Michael Urbich et al. PHARMACOECONOMICS
- Dapagliflozin and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Prior Myocardial Infarction: A Sub-analysis From DECLARE TIMI-58 Trial
- (2019) Remo H. M. Furtado et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-of-illness studies in heart failure: a systematic review 2004–2016
- (2018) Wladimir Lesyuk et al. BMC Cardiovascular Disorders
- Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
- (2018) Bianca Rocca et al. EUROPEAN HEART JOURNAL
- Fourth universal definition of myocardial infarction (2018)
- (2018) Kristian Thygesen et al. EUROPEAN HEART JOURNAL
- Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years: experiences from SWEDEHEART registry 1995 to 2014
- (2018) Karolina Szummer et al. EUROPEAN HEART JOURNAL
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
- (2017) Karolina Szummer et al. EUROPEAN HEART JOURNAL
- 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2017) Borja Ibanez et al. EUROPEAN HEART JOURNAL
- Risk and predictors of readmission for heart failure following a myocardial infarction between 2004 and 2013: A Swedish nationwide observational study
- (2017) Liyew Desta et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Oxygen Therapy in Suspected Acute Myocardial Infarction
- (2017) Robin Hofmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
- (2017) David Erlinge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atrial Fibrillation, Type 2 Diabetes, and Non–Vitamin K Antagonist Oral Anticoagulants
- (2017) Anna Plitt et al. JAMA Cardiology
- Outcome after percutaneous coronary intervention for different indications: long-term results from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)
- (2016) Marieke L. Fokkema et al. EuroIntervention
- 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
- (2015) Marco Roffi et al. EUROPEAN HEART JOURNAL
- Cardiovascular disease in Europe — epidemiological update 2015
- (2015) Nick Townsend et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
- (2015) Tomas Jernberg et al. EUROPEAN HEART JOURNAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
- (2011) S. J. Pocock et al. EUROPEAN HEART JOURNAL
- The Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
- (2010) T. Jernberg et al. HEART
- The Myocardial Ischaemia National Audit Project (MINAP)
- (2010) E. Herrett et al. HEART
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now